Weill Cornell Medicine · 3 months ago
Postdoctoral ScientistPositions Available in Cancer and Glioma Stem Cell Biology and Neurodevelopment Laboratory
Weill Cornell Medicine is seeking ambitious and creative scientists for postdoctoral fellowship positions in Cancer and Glioma Stem Cell Biology and Neurodevelopment. The role involves developing transformative therapies for glioblastoma by understanding the disease within the context of the human central nervous system, utilizing advanced technologies and models to drive research forward.
BiotechnologyEducationHealth CareInformation ServicesInformation TechnologyMedical
Responsibilities
Own a project end-to-end, from model design and assay development to data generation, analysis, and publication
Conduct high-throughput screens and perform deep mechanistic deconstruction of tumor-host interactions
Dissect complex systems using state-of-the-art technologies, including spatial transcriptomics, single-cell ATAC-seq, and CRISPR-based functional genomics
Employ computational approaches such as agent-based modeling to deconstruct gene-regulatory networks and predict system behaviors
Qualification
Required
PhD or MD/PhD in a relevant field
PhD in Molecular Biology, Genetics, cancer biology, neuroscience, and or developmental biology
Extensive experience with molecular, genetic, and cell biology
Excellent communication skills
Ability to work independently and as part of a team
Company
Weill Cornell Medicine
Weill Cornell Medicine is an academic medical institution that offers health care services.
H1B Sponsorship
Weill Cornell Medicine has a track record of offering H1B sponsorships. Please note that this does not
guarantee sponsorship for this specific role. Below presents additional info for your
reference. (Data Powered by US Department of Labor)
Distribution of Different Job Fields Receiving Sponsorship
Represents job field similar to this job
Trends of Total Sponsorships
2025 (171)
2024 (201)
2023 (198)
2022 (151)
2021 (151)
2020 (125)
Funding
Current Stage
Late StageTotal Funding
$69.8MKey Investors
National Institute of Allergy and Infectious DiseasesU.S. Department of DefenseNational Cancer Institute
2025-08-15Grant· $14.9M
2024-12-10Grant· $1.4M
2024-08-15Grant· $12.4M
Leadership Team
Recent News
2025-10-23
2025-04-24
Company data provided by crunchbase